glp-1 obesity drug news today 2025 Pharma Giants Bet on Next-Generation Treatments to Sustain Growth Study finds 40% of GLP-1
Description
Preclinical studies have confirmed that GIPRGLP1R coagonists improve several hallmarks of metabolic syndrome, such as obesity, hyperglycemia, and dyslipidemia
Think of your gut like a garden
They stand up to any scientific scrutiny
Learn how different GLP-1 medications work, how they differ for weight loss vs diabetes and why dual agonists like tirzepatide stand out.
This breakthrough formula fires up GLP-1 production to fend off cravings, especially those carb-loaded temptations
Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are a well-established class of glucose-lowering drugs
